113 related articles for article (PubMed ID: 38395183)
21. The combinational effect of E6/E7 siRNA and anti-miR-182 on apoptosis induction in HPV16-positive cervical cells.
Javadi H; Lotfi AS; Hosseinkhani S; Mehrani H; Amani J; Soheili ZS; Hojati Z; Kamali M
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):727-736. PubMed ID: 29873516
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer.
Kang SW; Kang OJ; Lee JY; Kim H; Jung H; Kim H; Lee SW; Kim YM; Choi EK
PLoS One; 2024; 19(2):e0298815. PubMed ID: 38363779
[TBL] [Abstract][Full Text] [Related]
23. LncRNA PCAT6 Accelerates the Progression and Chemoresistance of Cervical Cancer Through Up-Regulating ZEB1 by Sponging miR-543.
Ma Z; Gu G; Pan W; Chen X
Onco Targets Ther; 2020; 13():1159-1170. PubMed ID: 32103984
[TBL] [Abstract][Full Text] [Related]
24. ZNF143 mediates basal and tissue-specific expression of human transaldolase.
Grossman CE; Qian Y; Banki K; Perl A
J Biol Chem; 2004 Mar; 279(13):12190-205. PubMed ID: 14702349
[TBL] [Abstract][Full Text] [Related]
25. ZNF143 Suppresses Cell Apoptosis and Promotes Proliferation in Gastric Cancer via ROS/p53 Axis.
Zhang Y; Li Q; Wei S; Sun J; Zhang X; He L; Zhang L; Xu Z; Chen D
Dis Markers; 2020; 2020():5863178. PubMed ID: 32076462
[TBL] [Abstract][Full Text] [Related]
26. Analyzing the whole-transcriptome profiles of ncRNAs and predicting the competing endogenous RNA networks in cervical cancer cell lines with cisplatin resistance.
Lv H; Jin S; Zou B; Liang Y; Xie J; Wu S
Cancer Cell Int; 2021 Oct; 21(1):532. PubMed ID: 34641878
[TBL] [Abstract][Full Text] [Related]
27. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y
Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of
Tian J; Li Z; Jiang Y; Gu W; Kong E; Hao Q; Kong B; Sun L
Rejuvenation Res; 2022 Oct; 25(5):243-252. PubMed ID: 36039935
[TBL] [Abstract][Full Text] [Related]
29. Two Enhances the Cisplatin Sensitivity of Cervical Cancer Cells via Suppression of c-MET Expression.
Chen Z; Xiao Z; Tian W; Li Z; Wu T
Iran J Public Health; 2023 Jul; 52(7):1476-1486. PubMed ID: 37593506
[TBL] [Abstract][Full Text] [Related]
30. Role of microRNA-4739 in enhancing cisplatin chemosensitivity by negative regulation of RHBDD2 in human cervical cancer cells.
Li Y; Zhou Z; Qu J; Gong P; Wei Y; Sun Y
Cell Mol Biol Lett; 2024 Jan; 29(1):20. PubMed ID: 38267862
[TBL] [Abstract][Full Text] [Related]
31. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells.
Mahata S; Bharti AC; Shukla S; Tyagi A; Husain SA; Das BC
Mol Cancer; 2011 Apr; 10():39. PubMed ID: 21496227
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells.
Xu Y; Zheng Y; Duan Y; Ma L; Nan P
Oncol Lett; 2021 May; 21(5):392. PubMed ID: 33777215
[TBL] [Abstract][Full Text] [Related]
33. ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathway.
Dong Y; Hu M; Tan K; Dai R
Epigenetics; 2023 Dec; 18(1):2239592. PubMed ID: 37566742
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies.
Bhattacharjee R; Das SS; Biswal SS; Nath A; Das D; Basu A; Malik S; Kumar L; Kar S; Singh SK; Upadhye VJ; Iqbal D; Almojam S; Roychoudhury S; Ojha S; Ruokolainen J; Jha NK; Kesari KK
Crit Rev Oncol Hematol; 2022 Jun; 174():103675. PubMed ID: 35381343
[TBL] [Abstract][Full Text] [Related]
35. Low GAS5 expression may predict poor survival and cisplatin resistance in cervical cancer.
Fang X; Zhong G; Wang Y; Lin Z; Lin R; Yao T
Cell Death Dis; 2020 Jul; 11(7):531. PubMed ID: 32661236
[TBL] [Abstract][Full Text] [Related]
36. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
Wang T; Liu Z; Shi F; Wang J
Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
[TBL] [Abstract][Full Text] [Related]
37. Long Noncoding RNA Brain Cytoplasmic RNA 1 Induces Cisplatin-Resistance of Cervical Cancer Cells by Sponging MicroRNA-330-5p and Upregulating High-Mobility Group Box 3.
Sun D; Cao R; Han L; Yu X; Wang H; Wang X; Chen X
Gynecol Obstet Invest; 2022; 87(3-4):200-210. PubMed ID: 35705019
[TBL] [Abstract][Full Text] [Related]
38. iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling.
Xiong Y; Sun F; Dong P; Watari H; Yue J; Yu MF; Lan CY; Wang Y; Ma ZB
J Exp Clin Cancer Res; 2017 Apr; 36(1):48. PubMed ID: 28399926
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.
Koivusalo R; Krausz E; Helenius H; Hietanen S
Mol Pharmacol; 2005 Aug; 68(2):372-82. PubMed ID: 15908516
[TBL] [Abstract][Full Text] [Related]
40. Effect of Exosomal lncRNA MALAT1/miR-370-3p/STAT3 Positive Feedback Loop on PI3K/Akt Pathway Mediating Cisplatin Resistance in Cervical Cancer Cells.
Hu Y; Li G; Ma Y; Luo G; Wang Q; Zhang S
J Oncol; 2023; 2023():6341011. PubMed ID: 36793374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
